- Geyser
Brands continues to strengthen its leadership team with industry leaders
- The
company’s proprietary nanotechnology formulations transport therapeutic
agents with superior bioavailability and efficacy
- Geyser
Brands is pursuing the acquisition of Solace Management Group, solidifying
its place as a leading provider of health-focused CBD and hemp products
Geyser Brands Inc. (TSX.V: GYSR), a global science-led
consumer health care company, builds and markets some of the world’s leading
cannabis products and brands. As a licensed producer in Canada under the
Cannabis Act, Geyser operates a production and processing facility in Port
Coquitlam, British Columbia, developing unique products for healthy lifestyle
brands (http://ibn.fm/SFy2J).
One of Geyser’s wholly owned subsidiaries, Apothecary
Botanicals, recently received a standard processing license from Health Canada.
Receipt of the license was heralded by Geyser CEO Andreas Thatcher as “a huge
milestone” for the company.
“The license allows us to add value to existing consumer
health care brands by providing them the platform to add CBD,” Thatcher stated
in a news release (http://ibn.fm/eKxTj).
“It also reflects our business model to focus our licensed producer on
delivering scale through manufacturing and distribution for brand companies.”
The new license allows Geyser to begin work to extend its
cannabidiol products to the regulated Canadian consumer medical market as the
company awaits its R&D and sales licenses. Physical modifications to
the Apothecary Botanicals manufacturing facility to deliver GMP-compliant
capacity are complete, with production of in-house formulated branded products
expected to begin sometime in late summer.
With the completion of its proposed Solace Management Group
acquisition, Geyser intends to increase its production capacity with another
GMP facility dedicated to hemp-related human and pet products. These products
already feature the proprietary nanotechnology for stronger, more stable
offerings. The intention is to extend the Solace product and formulations into
the regulated cannabis space through Geyser’s licensed producer.
Adding strength to the company’s endeavors is the recent
addition of several seasoned industry leaders to its management team (http://ibn.fm/In1BX). Joining
the board of directors is Dr. Bin Huang, a seasoned life sciences executive
with experience in strategy and new business development, financing and public
markets, corporate governance and operations management in North America and
Asia.
Chartered Professional Accountant Gordon Clissold, who has
over 20 years of experience as an operational and financial manager for both
public and private companies, has been named chief financial officer. Clissold
has also served as a past president of the Certified General Accountants of BC.
These pivotal appointments to Geyser Brands’ leadership team are expected to
bring valuable oversight and experience to the company as it pursues strategic
goals in 2019 and beyond.
In combination with its proposed acquisition of Solace
Management Group, these additions are expected to play a key role in
establishing Geyser Brands as a leading provider of health-focused CBD and hemp
products (http://ibn.fm/jvaX5).
For more information, visit the company’s website at www.GeyserBrands.com
NOTE TO INVESTORS: The latest news and updates
relating to GYSR are available in the company’s newsroom athttp://ibn.fm/GYSR
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the QualityStocks
website applicable to all content provided by QS, wherever published or
re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment